Dr. Rachel Tanner

Biography

Rachel Tanner is an Associate Professor and Health Access Outreach Lead at the Department of Biology at the University of Oxford. Her research primarily focuses on Tuberculosis (TB), a major global health problem and the leading cause of death due to a single pathogen. Her research group employs a health approach to TB control, emphasizing the interconnected factors involving humans, animals, and the environment. Tanner's work includes the development of novel TB vaccines and drugs, with current projects centered on antigen discovery and the identification of humoral correlates of protection for rational vaccine design and evaluation, funded by the Academy of Medical Sciences. She serves as the lead principal investigator for the Oxford Consortium for Development of Drugs for Drug-resistant TB, funded by the Ineos Oxford Institute. Tanner has extensive experience in the development of functional assays for preclinical TB vaccine testing. Additionally, she collaborates with several organizations and universities on various projects related to vaccine development, particularly in exploring the social determinants of vaccine uptake among ethnic and racial minority groups. Tanner is involved in teaching topics related to immunology, infectious diseases, and genetics, and welcomes inquiries from prospective DPhil students interested in her research areas.

Research Interests

Experience